Three years after being diagnosed with malignant pleural mesothelioma, Ron Green proudly walked his youngest daughter down the aisle in a beautiful wedding…
Wally Rogers has beaten the long odds. He was diagnosed with the sarcomatoid subtype of mesothelioma in 2015. His life expectancy was limited, even with aggressive chemo. But he responded well to the immunotherapy drug Keytruda. It's kept his cancer under control.
Mesothelioma survivor Tina Herford is a testament to a rare combination of positive thinking, excellence in specialized care and the power of prayer. She…
Almost a year after chemotherapy had failed – and the end looked near – Barbara Lapalla was happily hosting another big family gathering, savoring…
The information on this website is proprietary and protected. It is not a substitute for professional medical advice, diagnosis or treatment. Any unauthorized or illegal use, copying or dissemination will be prosecuted. Please read our privacy policy and terms of service for more information about our website.
This website and its content may be deemed attorney advertising. Prior results do not predict a similar outcome.
The Mesothelioma Center’s claim as the most trusted resource is based on our more than 150 5-star Google and BBB reviews. Our organization also helps more than half of all mesothelioma patients annually diagnosed.
Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.
If you are looking for mesothelioma support, please contact our Patient Advocates at (855) 404-4592
Reviewed & Fact-Checked
This page was reviewed by:
Fact-checked and verified content:
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Please read our editorial guidelines to learn more about our content creation and review process.
